RecruitingNCT05597410

Shanghai At Risk for Alzheimer's Disease: a Cohort Study


Sponsor

Ruijin Hospital

Enrollment

3,418 participants

Start Date

Mar 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this cohort study is to estimate the incidence of AD in the first-degree relatives of patients with AD. The main questions it aims to answer are: * cognitive changes of subjects at high risk of AD as ageing; * environmental and behavioral factors affecting AD incidence.


Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This is a long-term study in Shanghai following family members of people who have been diagnosed with Alzheimer's disease (AD). Because first-degree relatives have a higher risk of developing AD, researchers want to study them over time to better understand how the disease develops and what early warning signs look like. **You may be eligible if...** - You are a parent, child, or sibling of someone diagnosed with Alzheimer's disease - You do not currently have Alzheimer's disease yourself - You are willing to be followed over many years **You may NOT be eligible if...** - You already have a diagnosis of Alzheimer's disease or another form of dementia - You have a serious medical condition that would make participation difficult - You are not a first-degree relative of someone with Alzheimer's disease Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05597410


Related Trials